Event Gaps: Perplexity's picks for 2026-10-14
Perplexity picked BAC, MS, BLK, SCHW, AA for a 1-day horizon. Intraday alpha vs SPY: +1.38%. Picks with positive alpha: 80%.
| Experiment | Event Gaps |
|---|---|
| Model | Perplexity |
| Prompt version | event-gap-v13 |
| Asked | |
| Horizon | 1-day |
| Measured from | 2026-10-14 |
| Measured to | 2026-10-15 |
| Benchmark | SPY |
| Status | Settled |
| Intraday alpha vs SPY | +1.38% |
| Picks with positive alpha | 80% |
| Benchmark return | -0.63% |
The picks
| Rank | Symbol | Gap direction | Price change | Return in the called direction | Confidence | vs benchmark | Called right |
|---|---|---|---|---|---|---|---|
| 1 | BAC | +3.34% | -3.34% | 68% | -2.70% | No | |
| 2 | MS | -1.80% | +1.80% | 58% | +2.43% | Yes | |
| 3 | BLK | +0.13% | -0.13% | 55% | +0.50% | Yes | |
| 4 | SCHW | -3.33% | +3.33% | 52% | +3.96% | Yes | |
| 5 | AA | -2.07% | +2.07% | 50% | +2.71% | Yes |
The model's market view
The one-session window spans a dense catalyst period: September U.S. CPI was scheduled for 8:30 a.m. ET on October 14, Bank of America, Morgan Stanley and BlackRock reported before the open, and Charles Schwab and Alcoa are scheduled to report on October 15. Rate sensitivity, financial-sector earnings quality and semiconductor/AI competition concerns are the dominant cross-currents; I favor downside exposure in names facing reported compliance, guidance or competitive pressure, with a modest contrarian long only where valuation and analyst support are strong.
Why each pick
BAC
Bank of America reported Q3 results before the October 14 open and separately disclosed a $1.21 billion Treasury/ OCC penalty for anti-money-laundering and sanctions-compliance failures; the company said Q3 results include a $1.2 billion non-tax-deductible charge reducing net income by $0.17 per share. These are observed facts, not expectations. Pre-market evidence showed BAC down about 6% before the open, indicating substantial but not necessarily complete incorporation of the fine and earnings impact. The remaining-session thesis is continued de-risking as investors assess compliance, litigation and reputational implications alongside a financial sector already pressured by mixed peer results; Citi fell 5.6% and Wells Fargo 3.1% after their reports. The strongest counter-evidence is that BAC entered with a Buy consensus and a $66.59 analyst target, and a sharp opening washout can attract dip buyers. The latest verifiable quote found was $53.26 in pre-market at 2026-10-14T06:04:00-04:00, a delayed/pre-market quote; no verified regular-session intraday open, high, low or cumulative volume was available at answering time. The required five completed daily bars, five-day return, 20-session high/low, 20-day average share volume and 20-day average dollar volume could not be verified from the sources available, so they are reported as null rather than estimated. A recovery above the pre-fine extended-hours area near $54.60 would invalidate the continued-downside thesis.
MS
Morgan Stanley reported Q3 2026 results before the October 14 open; RTTNews reported net income applicable to common shareholders rose to $4.91 billion, or $3.03 per share, from $4.61 billion, or $2.80 per share, a year earlier. That earnings growth is an observed fact. However, the broader bank complex traded poorly after mixed peer results, with Citi down 5.6% and Wells Fargo down 3.1% on revenue, investment-banking and credit concerns; the market is reportedly focused on forward guidance rather than headline beats. MS also entered with recent analyst price-target cuts and a Hold initiation, suggesting elevated expectations. I expect a modest downside continuation as investors discount wealth-management and dealmaking sensitivity to higher rates, despite the reported profit growth. The strongest counter-evidence is the reported year-over-year earnings growth and a Buy consensus with a $222.14 target. The latest verifiable quote available was $190.02 at the October 9 close; no verified October 14 intraday quote was found, so the reference price is a prior regular-session close and the elapsed-window move cannot be measured. The five completed daily bars, five-day return, 20-session range, 20-day average volume and 20-day dollar volume could not be verified and are null. A close back above $195 would challenge the downside thesis.
BLK
BlackRock was scheduled to report Q3 2026 results before the October 14 open, and its stock was already down 1.38% intraday at $1,068.92 as of 2026-10-14T14:29:00-04:00, a live market-open quote. The stock had also slumped into a correction over the prior four weeks, according to Invezz coverage cited on its quote page, while multiple banks cut price targets in the week before results. The observed pre-report weakness suggests some pessimism was already priced in, but I expect continued downside if results or flows fail to reverse concerns about private-credit and asset-management sentiment. The strongest counter-evidence is the Strong Buy consensus, a $1,315.59 average target and recent positive business developments, including the Humana/HPS joint venture and AT&T fiber JV involvement. The five completed daily bars, five-day return, 20-session high/low, 20-day average share volume and 20-day average dollar volume could not be verified from the available sources and are null. A sustained move above $1,090, the upper end of the observed intraday range, would invalidate the downside thesis.
SCHW
Charles Schwab is officially scheduled to report Q3 2026 results before the open on October 15, within the forecast window. This is a scheduled event, not an observed outcome. Anticipation can move the stock during October 14 as traders position for results. The bearish lean reflects recently reported competitive pressure from AI-driven brokerage alternatives, heavy bearish options flow noted about three weeks earlier, and a sequence of mixed analyst target revisions; Truist lowered its target to $125 while TD Cowen raised theirs to $129. The stock closed October 13 at $95.94, below its 52-week high of $114.53, indicating a weak trend into the print. The strongest counter-evidence is the Buy consensus, $122.32 average target and Schwab's strong recent revenue and earnings growth. The latest verifiable quote was $96.22 in after-hours at 2026-10-13T19:58:00-04:00; no verified October 14 intraday quote was found. The five completed daily bars, five-day return, 20-session range, 20-day average volume and 20-day dollar volume could not be verified and are null. A pre-earnings rally through $98 would invalidate the downside anticipation thesis.
AA
Alcoa is officially scheduled to announce Q3 2026 results after the close on October 15, 2026, according to its Business Wire announcement; that is after the forecast window ends at 14:38 UTC on October 15, so the position is an anticipation trade rather than a post-earnings reaction. The bearish lean reflects recent analyst estimate and target reductions: Morgan Stanley cut its target to $50, JPMorgan to $50, and Wells Fargo to $60, with aluminum-forecast and cost-headwind concerns cited. The stock traded at $40.94 intraday on October 13, down 1.75%, and sits far below its 52-week high of $84.38, indicating a depressed trend. The strongest counter-evidence is the Buy consensus, $60.31 average target, low 8.64 trailing P/E and the company's stated expectation of $900 million in acquisition synergies. The five completed daily bars, five-day return, 20-session high/low, 20-day average share volume and 20-day average dollar volume could not be verified from the available sources and are null. A move above $42 would invalidate the pre-earnings downside anticipation thesis.
Other models on the same run
| Model | Picks | Intraday alpha vs SPY | Picks with positive alpha |
|---|---|---|---|
| Meta AI - Muse Spark | ASML, BLK, BAC, TSM, MS | -1.84% | 40% |
| Gemini 3 Pro | AAPL, MSFT, NVDA, AMZN, GOOGL | -0.92% | 20% |
| Grok 4.5 | BAC, BLK, MS, ASML, TSM | -2.56% | 20% |
| GPT-6 | PNC, PLD, BNY, USB, SCHW | -0.24% | 40% |
| DeepSeek | TSM, SCHW, GME, BAC, PGR | -3.53% | 0% |
Written up on ForecastNest Insights: Event Gaps: Perplexity's picks for 2026-10-14.
ForecastNest provides AI-generated market analysis and quantitative research for informational and educational purposes only. Nothing here constitutes financial, investment, legal, or tax advice.